Pathology, research and practice · 2015
An unusual association of malignant gastrointestinal neuroectodermal tumor (clear cell sarcoma-like) and Ewing sarcoma.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Insabato Luigi, Guadagno Elia, Natella Valentina, Somma Anna, Bihl Michel, Pizzolorusso Antonio, Mainenti Pier Paolo, Apice Gaetano, Tornillo Luigi
Аннотация
Very recently a new designation of "Malignant Neuroectodermal Gastrointestinal Tumor" has been proposed for an aggressive form of neuroectodermal tumor with features similar to that of Clear Cell Sarcoma of Soft Tissue, however without a melanocytic differentiation. Also known as "clear cell sarcoma-like tumors of the gastrointestinal tract", these tumors show some features strongly suggesting an origin from a gastrointestinal neuroectodermal precursor cell unable to differentiate along the melanocytic lineage. They occur mainly in young and middle-aged adults, and have a poor prognosis with a high rate of liver and lymphnode metastases. Histologically they are composed of epithelioid or oval-to spindle cells with a sheet-like or nested pattern of growth, strongly positive for neural markers (S-100, SOX10, and vimentin) and negative for the melanocytic ones. EWSR1 gene rearrangements including EWSR1-ATF1 or EWSR1-CREB1 GENE fusions are typically assessed in these tumors. Here we report a case of malignant neuroectodermal gastrointestinal tumor which immunophenotypically unusually expressed FLI-1, occurring in a 29-year-old man with a previous medical history of Ewing sarcoma. We finally suggest that this case might be a further evidence of a link between these two entities.
Предметные рубрики MeSH
AdultAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBiopsyBone NeoplasmsChemotherapy, AdjuvantGastrectomyHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMagnetic Resonance ImagingMaleNeoplasms, Second PrimaryNeuroectodermal Tumors, PrimitivePolymerase Chain ReactionSarcoma, Clear CellSarcoma, EwingStomach NeoplasmsTreatment Outcome